Eli Lilly CEO David Ricks Receives Award of 38,914 Shares

What Happened David A. Ricks, President, Chair, CEO and a director of Eli Lilly & Co. (LLY), was granted 38,913.584 shares as an award on February 9, 2026. The filing reports a per-share valuation of $1,044.67, for a total value of approximately $40,651,854. This was an award/grant (compensation) transaction rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-09; Filing date: 2026-02-11 (filed two days after the transaction, which appears timely under Form 4 rules).
• Instrument/Code: A (award/grant); reported price/value: $1,044.67 per share; total reported value: $40,651,854.
• Shares granted: 38,913.584.
• Shares owned after transaction: Not specified in the Form 4 provided.
• Footnote: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Context

• An "A" code indicates a compensation grant (e.g., RSUs or similar awards). Such grants are part of executive compensation and do not necessarily signal a personal market purchase or sale decision.
• This is informative about executive pay and alignment with shareholders, but it is not the same as a direct cash purchase; treat it as routine grant-based compensation unless other filings indicate immediate sales or hedging.